, Tracking Stock Market Picks
Enter Symbol:
Medtronic, Inc. (MDT) [hlAlert]

up 73.47 %

Medtronic, Inc. (MDT) rated Buy with price target $55 by Mizuho

Posted on: Monday,  May 20, 2013  8:25 AM ET by Mizuho

Mizuho rated Buy Medtronic, Inc. (NYSE: MDT) on 05/20/2013. Previously Mizuho rated Buy Medtronic, Inc. (NYSE: MDT) on 01/03/2013., when
the stock price was $42.38. Since then, Medtronic, Inc. has gained 73.48% as of 08/27/2015's recent price of $73.52.
If you would have followed the previous Mizuho's recommendation on MDT, you would have gained 73.47% of your investment in 966 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/20/2013 8:25 AM Buy
49.75 55.00
as of 12/13/2013
1 Week down  -3.86 %
1 Month down  -3.95 %
3 Months up  4.31 %
1 YTD up  12.34 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/19/2013 2:25 PM Buy
45.80 52.00
1/3/2013 8:25 AM Buy
42.38 49.00
11/21/2012 8:25 AM Hold
42.63 43.00
8/22/2012 8:25 AM Hold
41.20 41.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy